文献速递癫痫

胶质母细胞瘤患者癫痫的复杂性

The complexities underlying epilepsy in people with glioblastoma.
PubMed 文献 · Lancet Neurol · 2023-04-27

本文综述了胶质母细胞瘤患者癫痫的病理生理机制,涉及肿瘤组织内在致痫性、肿瘤及瘤周微环境改变以及邻近脑结构的物理和功能扰动。癫痫管理仍具挑战性,抗癌治疗与抗癫痫药物间的药物相互作用及药物副作用可影响癫痫控制和生活质量。新疗法的癫痫效应尚未完全明确,亟需大规模随机临床试验。

要点

  • 胶质母细胞瘤患者癫痫的病理生理涉及肿瘤内在致痫性、微环境改变及邻近脑结构扰动。
  • 抗癌治疗与抗癫痫药物的相互作用及副作用影响癫痫控制和生活质量。
  • 新疗法对癫痫的影响尚未完全明确,亟需大规模随机临床试验。

核心结论

  • 胶质母细胞瘤患者癫痫的病理生理涉及肿瘤组织内在致痫性、肿瘤及瘤周微环境改变以及邻近脑结构的物理和功能扰动。
  • 癫痫管理仍具挑战性,药物相互作用和副作用可影响癫痫控制和生活质量。
  • 新疗法对癫痫的影响尚未完全明确,亟需大规模随机临床试验。

研究设计与样本

  • 综述文章,总结过去5年的进展,包括新的临床试验数据。

主要发现

  • 胶质母细胞瘤患者癫痫的病理生理与肿瘤组织内在致痫性、肿瘤及瘤周微环境改变以及邻近脑结构的物理和功能扰动有关。
  • 抗癌治疗与抗癫痫药物间的药物相互作用及药物副作用可影响癫痫控制和生活质量。
  • 新疗法对癫痫的影响尚未完全明确。
  • 肿瘤组织的电活动作为肿瘤细胞生长驱动因素及内在超兴奋性可能成为治疗和疾病修饰的靶点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 新疗法对癫痫的影响尚未完全明确。
  • 亟需大规模随机临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Seizures are among the most common clinical signs in people with glioblastoma. Advances over the past 5 years, including new clinical trial data, have increased the understanding of why some individuals with glioblastoma are susceptible to seizures, how seizures manifest clinically, and what implications seizures have for patient management. The pathophysiology of epilepsy in people with glioblastoma relates to a combination of intrinsic epileptogenicity of tumour tissue, alterations in the tumour and peritumoural microenvironment, and the physical and functional disturbance of adjacent brain structures. Successful management of epilepsy in people with glioblastoma remains challenging; factors such as drug-drug interactions between cancer therapies and antiseizure medications, and medication side-effects, can affect seizure outcomes and quality of life. Advances in novel therapies provide some promise for people with glioblastoma; however, the effects of these therapies on seizures are yet to be fully determined. Looking forward, insights into electrical activity as a driver of tumour cell growth and the intrinsic hyperexcitability of tumour tissue might represent useful targets for treatment and disease modification. There is a pressing need for large randomised clinical trials in this field.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Sokolov E, Dietrich J, Cole AJ, et al. The complexities underlying epilepsy in people with glioblastoma. Lancet Neurol. 2023. PMID: 37121239. doi:10.1016/S1474-4422(23)00031-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。